AACR 2026 Highlights

AACR 2026 has officially wrapped – and what an incredible week it has been!

We were thrilled to welcome researchers from around the world to Booth #1941, where conversations centered on advancing cancer research through scalable, consistent, and clinically relevant models.

A key highlight was the strong interest in our end-to-end xeno-free 3D cell culture platform—featuring VitroGel® hydrogels, RocketCell™ media, CytoGrow™ growth factors, VitroPrime™ cultureware, and Cyto3D® analysis. Built to support the transition to New Approach Methodologies (NAMs), this integrated solution streamlines workflows across organoids, xenograft, 3D spheroids, invasion assays, and other advanced 3D systems.

Five professionals pose in front of an 'Annual Meeting' banner on the left and a VitroGel biotech booth on the right, at a conference display collage.
Collage of a biotech trade show: attendees explore booth demos, product displays, and posters at multiple Vulcan/Well Biotech booths with a prize wheel and plush mascots present.

Key Moments

A major highlight was the unveiling of new data and insights through our poster presentations, highlighting the versatility of VitroGel®-based 3D models and their growing impact in advancing cancer research across diverse applications.

Three researchers stand beside large biomedical poster boards at a conference, presenting study summaries on tumor models and drug development.

XENOGRAFT
POSTER # 2175
in collaboration with

Towards ethical and robust drug development: Comprehensive validation of an animal-free matrix for in vivo tumor models

Learn More

TUMOROID
POSTER # 4832

Developing Advanced Tumoroid Models Driven by Epithelial-to-Mesenchymal Transition with a Novel Xeno-Free and Biofunctional Hydrogel System

Learn More

ORGANOID
POSTER # 4863

Innovative xeno-free synthetic hydrogel supports iPSC-derived intestinal organoids and colorectal cancer (CRC) organoid growth, an advanced organoid platform for therapeutic screening

Learn More

AACR wouldn’t be complete without a little fun—Alexis TheWhale made a splash at our booth, bringing smiles and great energy throughout the event.

We’re thrilled to congratulate our lucky winners from our social media follower draw for the KING-SIZE Alexis TheWhale! Thank you to everyone who participated, connected with us, and helped make this initiative such a memorable part of AACR 2026.

Three photos from a biotech expo: people posing with a blue plush mascot in front of TheWell/Bioscience booths advertising 3D cell culture products like Vitroprime vessels and organoid models.

Key Product Launches

Another major highlight was the launch of our latest innovations, including the RocketCell™ Organoid Xeno-Free Essential-Core Medium and the VitroPrime™ 3D Culture and Imaging Plate. These solutions are designed to simplify organoid workflows and enable more consistent, high-quality 3D culture and imaging—further strengthening our end-to-end xeno-free platform.

VitroPrime™ 3D Culture and Imaging Plate

A premium cover-glass bottom plate for zero disruption 3D cell culture workflow: From cell seeding to high-resolution imaging. Available sizes: 6-well, 24-well, 96-well

Learn More > 

RocketCell™ Organoid Xeno-Free Essential-Core Medium

A ready-to-use, chemically defined medium that simplifies organoid culture. It provides essential nutrients and can be easily combined with growth factors to support different organoid types, removing the need for conditioned media or complex mixing.

Learn More > 

CytoGrow™ Premium
Growth Factors

Premium-grade recombinant proteins, delivering high bioactivity, strong lot-to-lot consistency, and reliable performance with research-friendly pricing.

Learn More > 

Thank You for a Successful AACR 2026

To everyone who visited our booth, joined our discussions, and shared your insights—thank you. Your engagement made this AACR a truly memorable experience.

If you were unable to attend or would like to continue the conversation, our team would be happy to connect and support your 3D culture research needs.